U.S. Patent and Trademark Office Publishes Immatics Biotechnologies's Patent Application for Novel Immunotherapy Against Several Tumors of the Blood, Such as Acute Myeloid Leukemia (AML)

Published date15 January 2021
The patent application number is 17/039032. International Patent Classification codes are A61K 39/00 20060101 A61K039/00, C07K 14/47 20060101 C07K014/47, G01N 33/50 20060101 G01N033/50, C12Q 1/6886 20060101 C12Q001/6886, C12N 9/90 20060101 C12N009/90, C12N 9/14 20060101 C12N009/14, A61K 35/17 20060101 A61K035/17, C07K 7/02 20060101 C07K007/02, C07K 7/08 20060101 C07K007/08, C07K 7/06 20060101 C07K007/06 and C07K 14/725 20060101 C07K014/725. Cooperative Patent Classification codes are C12Q 2600/136 20130101, G01N 33/505 20130101, A61K 2039/5158 20130101, A61K 35/17 20130101, A61K 39/0011 20130101, C12Y 306/04004 20130101, C07K 14/4748 20130101, C07K 7/08 20130101, C12N 5/0638 20130101, C07K 14/7051 20130101, C07K 7/02 20130101, A61K 2039/572 20130101, A61K 2039/5156 20130101, C12Q 1/6886 20130101, C07K 7/06 20130101, C07K 2319/70 20130101, C12N 9/90 20130101, C07K 14/47 20130101, C12Y 599/01002 20130101 and C12N 9/14 20130101.

U.S. Patent and Trademark Office has...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT